North Carolina State Researchers Test Dental Floss as Needle-Free Vaccine Delivery Method

Key points

• North Carolina State University researchers are testing a novel vaccine delivery method using dental floss.
• The technique exploits the permeable tissue between teeth and gums to administer vaccines without needles.
• This route aims to trigger a stronger mucosal immune response, targeting viruses that first attack the nose, mouth, and lungs.
• The method could eliminate the need for cold storage and allow for self-administration at home.
• The approach is intended for older children and adults, as it cannot replace traditional shots for infants who lack teeth.
• Early studies have shown promising results, with human trials identified as the next phase of research.

Background

This development follows recent advancements in alternative drug delivery systems, such as the University at Buffalo's hydrogel depot for osteoarthritis, which aims to reduce injection frequency. It also arrives as the 2026-2027 fall vaccination season approaches, with updated flu and COVID-19 shots targeting new variants like H3N2 subclade K and the XFG (Stratus) variant. While current efforts focus on expanding access through standing orders and pharmacy rollouts, the floss-based method represents a distinct shift toward routine, needle-free prevention.

Why it matters

Needle phobia remains a significant barrier to vaccine uptake, keeping many individuals from receiving protection against over 30 life-threatening diseases. A floss-based delivery system could integrate vaccination into daily hygiene routines, potentially increasing compliance and accessibility. By avoiding cold storage requirements and enabling self-administration, this method could reduce logistical burdens and healthcare costs, making preventive care more convenient for the general population.

What to watch

The immediate next step is the initiation of human trials to validate the efficacy and safety of the floss-based vaccine delivery system. Researchers will need to determine the optimal dosage and formulation for the permeable gum tissue. If successful, this method could eventually be commercialized for older children and adults, offering a needle-free alternative for diseases like flu, shingles, and HPV, though it will not replace traditional shots for infants.